GTR Home > Tests > Search results - Nemaline myopathy 5

Apply filters

Showing test for 1 condition

reset

Compare labs

  • Hide states

GTR test search results for C1854380[DISCUI]

C Clinical test, R Research test

Showing 1 to 14 of 14 tests for 1 condition in 6 labs

CCongenital Myopathy Deletion/Duplication Analysis

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Total conditions (25)
Total targets (17)

CNemaline Myopathy Panel (7 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (8)
Total targets (7)

CMyoGene Panel (43 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (95)
Total targets (43)

CCongenital Myopathy Panel (14 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (27)
Total targets (14)

CNemaline myopathy type 5

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNemaline Myopathy Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (9)
Total targets (9)

CCongenital Myopathy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (20)
Total targets (19)

CNemaline Myopathy 5 (Amish Nemaline Myopathy) via the TNNT1 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CTNNT1

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNemaline Myopathy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (7)

CExpanded Neuromuscular Disorders: Sequencing and Deletion/Duplication Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (154)
Total targets (79)

CNeuromuscular Disorders: Gene Sequencing and Deletion/Duplication Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (102)
Total targets (46)

CNeuromuscular NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (126)
Total targets (50)

CNemaline Myopathy, TNNT1-Related: TNNT1 Gene Deletion/Duplication

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Test targets
Methods
  • D Deletion/duplication analysis

Showing 1 to 14 of 14 tests for 1 condition in 6 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.